Skip to content

OrthoPediatrics KIDS Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Medtronic logo
MedtronicMDT
Globus Medical logo
Globus MedicalGMED
IAR
Integra LifeSciencesIART
CONMED logo
CONMEDCNMD
ClearPoint Neuro logo
ClearPoint NeuroCLPT
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's finite-lived intangible assets, accumulated amortization?
OrthoPediatrics (KIDS) reported finite-lived intangible assets, accumulated amortization of $40.21M in Q1 2026.
How has OrthoPediatrics's finite-lived intangible assets, accumulated amortization changed year-over-year?
OrthoPediatrics's finite-lived intangible assets, accumulated amortization increased by 29.5% year-over-year, from $31.04M to $40.21M.
What is the long-term trend for OrthoPediatrics's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), OrthoPediatrics's finite-lived intangible assets, accumulated amortization has grown at a 51.0% compound annual growth rate (CAGR), from $4.83M to $37.92M.